slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
16.650 KRW | +3,93% | -10,39% | -2,63% |
2023 | Jeil Pharmaceutical Co.,Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2023 | CI |
2022 | Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan verlengd tot 9 december 2022. | CI |
Omzet 2022 | 722 mld. 524 mln. 492 mln. | Omzet 2023 | 726 mld. 527 mln. 495 mln. | Marktkapitalisatie | 249 mld. 181 mln. 170 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -13,09 mld. -9,49 mln. -8,91 mln. | Nettowinst (verlies) 2023 | 5 mld. 3,63 mln. 3,41 mln. | EV/omzet 2022 | 0,46 x |
Nettoschuld 2022 | 22,76 mld. 16,5 mln. 15,5 mln. | Nettoschuld 2023 | 35,51 mld. 25,75 mln. 24,18 mln. | EV/omzet 2023 | 0,39 x |
K/w-verhouding 2022 |
-23,4
x | K/w-verhouding 2023 |
49,9
x | Werknemers | 964 |
Dividendrendement 2022 |
0,24% | Dividendrendement 2023 |
-
| Vrij verhandelbaar | 36,82% |
1 dag | +3,93% | ||
1 week | -10,39% | ||
Lopende maand | -0,30% | ||
1 maand | +0,06% | ||
3 maanden | +0,60% | ||
6 maanden | +5,78% | ||
Lopend jaar | -2,63% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Seok-Jae Sung
CEO | Chief Executive Officer | 63 | - |
Chang-Seok Lee
CTO | Chief Tech/Sci/R&D Officer | 64 | - |
Chi-Guk No
BRD | Director/Board Member | 52 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sang-Cheol Han
BRD | Director/Board Member | 48 | - |
Seok-Jae Sung
CEO | Chief Executive Officer | 63 | - |
Chi-Guk No
BRD | Director/Board Member | 52 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 16.650 | +3,93% | 99 203 |
17-04-24 | 16.020 | -2,20% | 54 296 |
16-04-24 | 16.380 | -1,74% | 84 606 |
15-04-24 | 16.670 | -5,71% | 127 112 |
12-04-24 | 17.680 | -4,84% | 313 596 |
slotkoers Korea S.E., 18 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-2,63% | 176 mln. | |
+20,46% | 43,54 mld. | |
+16,96% | 21,74 mld. | |
+8,37% | 13,02 mld. | |
+4,84% | 13,53 mld. | |
+32,96% | 11,28 mld. | |
-11,05% | 6,99 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+7,71% | 5,09 mld. |